Tag: Eli Lilly
Business & Industry
Eli Lilly and Mubadala Bio Sign Abu Dhabi GLP-1 Packaging Agreement
Eli Lilly and Mubadala Bio have signed a formal agreement to develop local pharmaceutical packaging and logistics capabilities for Lilly's GLP-1 medicines in Abu...
Business & Industry
Lilly and BioArctic Partner on BrainTransporter Technology
Eli Lilly and Company has entered into a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to advance a potential treatment for neurodegenerative...
Business & Industry
Eli Lilly Genetic Medicine Push Expands with Ascidian Deal
Eli Lilly has entered into a research collaboration with Ascidian Therapeutics aimed at discovering and developing treatments for kidney diseases, marking another step in...
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is...
Business & Industry
Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy
After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...
Business & Industry
Eli Lilly Kelonia Acquisition Advances in $2B Deal Talks
Eli Lilly and Company is in advanced discussions to acquire Kelonia Therapeutics for more than $2 billion, according to a report by The Wall...
Business & Industry
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly & Co. is set to acquire Centessa Pharmaceuticals Plc in a transaction worth up to $7.8 billion, underscoring its push to broaden...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read